Search

Your search keyword '"Rothenberg, Marc E"' showing total 3,256 results

Search Constraints

Start Over You searched for: Author "Rothenberg, Marc E" Remove constraint Author: "Rothenberg, Marc E"
3,256 results on '"Rothenberg, Marc E"'

Search Results

207. Novel targeted therapies for eosinophilic disorders

212. ICON: Eosinophil Disorders

214. A Deep Multi-Label Segmentation Network For Eosinophilic Esophagitis Whole Slide Biopsy Diagnostics

215. Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant Methods

216. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions

219. The mast cell pain connection in eosinophilic esophagitis

220. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.

221. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)

222. DR. ROTHENBERG AND COLLEAGUES REPLY.

230. Eosinophilic esophagitis: Updated consensus recommendations for children and adults

232. Epigenetic and transcriptional dysregulation in CD4+ T cells in patients with atopic dermatitis

233. Direct-to-Consumer Recruitment Methods for Clinical Trials for Rare Diseases: Novel Approach for Testing the Application of Targeted Social Media Messaging to Aid in Accrual Into Research Studies (Preprint)

234. Direct-to-Consumer Recruitment Methods for Clinical Trials for Rare Diseases: A Novel Approach for Testing the Application of Targeted Social Media Messaging to Aid in Accrual Into Research Studies (Preprint)

235. Su1167: THE ASSOCIATION BETWEEN HISTOLOGIC ABNORMALITIES AND HEALTH RELATED QUALITY OF LIFE IN PEDIATRIC PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

236. 989: DUPILUMAB IMPROVES HISTOLOGIC AND CLINICAL ASPECTS OF DISEASE IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AT WEEK 24: RESULTS FROM PART B OF THE 3-PART LIBERTY EOE TREET STUDY

237. 867a: CLINICAL AND HISTOLOGICAL IMPROVEMENTS WITH WEEKLY DUPILUMAB TREATMENT IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AT WEEK 24: WEEKLY AND EVERY 2 WEEKS’ RESULTS FROM PART B OF THE 3-PART LIBERTY EOE TREET STUDY

238. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

240. An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes

241. Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis

242. Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells

243. Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab

244. Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field

245. Management of eosinophilic esophagitis associated food impaction in Europe and the United States

250. List of Contributors

Catalog

Books, media, physical & digital resources